These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 23089469)

  • 1. High therapeutic concentration of prazosin up-regulates angiogenic IL6 and CCL2 genes in hepatocellular carcinoma cells.
    Lin ZY; Chuang WL
    Biomed Pharmacother; 2012 Dec; 66(8):583-6. PubMed ID: 23089469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic concentrations of ascorbic acid cause diverse influence on differential expressions of angiogenic chemokine genes in different hepatocellular carcinoma cell lines.
    Lin ZY; Chuang WL
    Biomed Pharmacother; 2010 May; 64(5):348-51. PubMed ID: 19932582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-associated fibroblasts up-regulate CCL2, CCL26, IL6 and LOXL2 genes related to promotion of cancer progression in hepatocellular carcinoma cells.
    Lin ZY; Chuang YH; Chuang WL
    Biomed Pharmacother; 2012 Oct; 66(7):525-9. PubMed ID: 22739041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphotericin B up-regulates angiogenic genes in hepatocellular carcinoma cell lines.
    Lin ZY; Chuang WL; Chuang YH
    Eur J Clin Invest; 2009 Mar; 39(3):239-45. PubMed ID: 19260954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic concentrations of melatonin have diverse influence on differential expressions of angiogenic chemokine genes in different hepatocellular carcinoma cell lines.
    Lin ZY; Chuang WL
    Biomed Pharmacother; 2010 Dec; 64(10):659-62. PubMed ID: 20970952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma cells cause different responses in expressions of cancer-promoting genes in different cancer-associated fibroblasts.
    Lin ZY; Chuang WL
    Kaohsiung J Med Sci; 2013 Jun; 29(6):312-8. PubMed ID: 23684136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-cancer mechanisms of clinically acceptable colchicine concentrations on hepatocellular carcinoma.
    Lin ZY; Wu CC; Chuang YH; Chuang WL
    Life Sci; 2013 Sep; 93(8):323-8. PubMed ID: 23871804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genes responsible for the characteristics of primary cultured invasive phenotype hepatocellular carcinoma cells.
    Lin ZY; Chuang WL
    Biomed Pharmacother; 2012 Sep; 66(6):454-8. PubMed ID: 22681909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain-derived neurotrophic factor promotes tumorigenesis via induction of neovascularization: implication in hepatocellular carcinoma.
    Lam CT; Yang ZF; Lau CK; Tam KH; Fan ST; Poon RT
    Clin Cancer Res; 2011 May; 17(10):3123-33. PubMed ID: 21421859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma.
    Lau CP; Poon RT; Cheung ST; Yu WC; Fan ST
    J Pathol; 2006 Dec; 210(4):459-68. PubMed ID: 17029219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Berberine inhibits angiogenic potential of Hep G2 cell line through VEGF down-regulation in vitro.
    Jie S; Li H; Tian Y; Guo D; Zhu J; Gao S; Jiang L
    J Gastroenterol Hepatol; 2011 Jan; 26(1):179-85. PubMed ID: 21175812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined functional genome survey of therapeutic targets for hepatocellular carcinoma.
    Satow R; Shitashige M; Kanai Y; Takeshita F; Ojima H; Jigami T; Honda K; Kosuge T; Ochiya T; Hirohashi S; Yamada T
    Clin Cancer Res; 2010 May; 16(9):2518-28. PubMed ID: 20388846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The apoptosis inducing effect of Glycosmis pentaphylla (Retz.) Correa and its influence on gene expression in hepatocellular carcinoma cell line, Hep3 B.
    Sreejith PS; Mascarenhas RR; Praseeja RJ; Asha VV
    J Ethnopharmacol; 2012 Jan; 139(2):359-65. PubMed ID: 22138516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta-catenin siRNA regulation of apoptosis- and angiogenesis-related gene expression in hepatocellular carcinoma cells: potential uses for gene therapy.
    Wang XH; Sun X; Meng XW; Lv ZW; Du YJ; Zhu Y; Chen J; Kong DX; Jin SZ
    Oncol Rep; 2010 Oct; 24(4):1093-9. PubMed ID: 20811694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma.
    Cheng AS; Chan HL; To KF; Leung WK; Chan KK; Liew CT; Sung JJ
    Int J Oncol; 2004 Apr; 24(4):853-60. PubMed ID: 15010822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of zinc finger 23 gene in human hepatocellular carcinoma.
    Shi Y; Zheng L; Luo G; Wei J; Zhang J; Yu Y; Feng Y; Li M; Xu N
    Anticancer Res; 2011 Oct; 31(10):3595-9. PubMed ID: 21965783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma.
    Kim JK; Jung KH; Noh JH; Eun JW; Bae HJ; Xie HJ; Ahn YM; Ryu JC; Park WS; Lee JY; Nam SW
    Int J Oncol; 2009 Dec; 35(6):1257-64. PubMed ID: 19885547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C/EBPalpha is up-regulated in a subset of hepatocellular carcinomas and plays a role in cell growth and proliferation.
    Lu GD; Leung CH; Yan B; Tan CM; Low SY; Aung MO; Salto-Tellez M; Lim SG; Hooi SC
    Gastroenterology; 2010 Aug; 139(2):632-43, 643.e1-4. PubMed ID: 20347819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma.
    Xie Q; Chen X; Lu F; Zhang T; Hao M; Wang Y; Zhao J; McCrae MA; Zhuang H
    Cancer; 2012 May; 118(9):2431-42. PubMed ID: 21989846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.
    Gho JW; Ip WK; Chan KY; Law PT; Lai PB; Wong N
    Cancer Res; 2008 Aug; 68(16):6743-51. PubMed ID: 18701499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.